With 25 sites recruiting, most of the trial expens
Post# of 72437
![Avatar](/images/ProfileImages/398685088_3064_306524.png)
"As of September 30, 2016, we had approximately $5.6 million in cash and cash equivalents and $20 million remaining available for stock sales under the terms of the purchase agreement with Aspire Capital, compared to $6.3 million of cash and cash equivalents as of June 30, 2016."
https://www.sec.gov/Archives/edgar/data/13552...ix_10q.htm
Quote:
All I know is what Leo said of the P2B costs (6/7 mil). We don't know the current cash position and how much more will be needed?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
![Dont-give-up.jpg](https://styleshack.com/wp-content/uploads/2014/07/Dont-give-up.jpg)